8 completed. 4 Not applicable, 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 4 |
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 3 | Completed 3 |
Follow Immediate Hypersensitivity: new trials by email Literature Review of Immediate Hypersensitivity trials Research Report on Immediate Hypersensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Standardised Drug Provocation Testing in Perioperative Hypersensitivity Full dose DPT with propofol, Full dose DPT with ketamine, Full dose DPT with etomidate - Allergic Reaction, Hypersensitivity | Not applicable | Completed | University Hospital, Antwerp | 50 | 2023-10-23 | 2025-09-08 |
| Comparison Between spIgE and Skin Prick Test of Local and Imported Aeroallergens Skin prick test, specific IgE measurement - Immediate Hypersensitivity | Not applicable | Completed | Mahidol University | 84 | 2013-11-01 | 2016-05-04 |
| Comparison of Difference Histamine Concentration (1, 5 and 10 mg/ml) for Skin Prick Test Positive Control SPT - Immediate Hypersensitivity | Not applicable | Completed | Mahidol University | 180 | 2013-07-01 | 2016-05-03 |
| Diagnosis and Physiopathology of Insulin Allergy Allergy tests - Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | Not applicable | Completed | Assistance Publique - Hôpitaux de Paris | 55 | 2012-02-06 | 2025-09-12 |
| A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy Peanut powder, Peanut extract, Placebo extract - Peanut Hypersensitivity, Food Hypersensitivity | Phase 1 / Phase 2 | Completed | Johns Hopkins University | 21 | 2010-03-01 | 2017-04-07 |
| Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults E. Coli-Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3 - Food Hypersensitivity, Hypersensitivity | Phase 1 | Completed | Allertein Therapeutics, LLC | 15 | 2009-10-01 | 2013-05-27 |
| A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial Glycerinated peanut allergenic extract, Placebo for peanut extract (glycerin) - Food Hypersensitivity, Hypersensitivity | Phase 1 / Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 40 | 2007-12-01 | 2019-08-21 |
| Oral Immunotherapy for Childhood Egg Allergy Egg oral immunotherapy, Control Group - Hypersensitivity, Immediate Hypersensitivity | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 55 | 2007-05-01 | 2017-12-13 |
Hypersensitivity, Immediate (8) · Hypersensitivity (5) · Food Hypersensitivity (4) · Peanut Hypersensitivity (3) · Anaphylaxis (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 1 (1) · Diabetes Mellitus, Type 2 (1) · Drug Hypersensitivity (1) · Drug-Related Side Effects and Adverse Reactions (1) · Egg Hypersensitivity (1)
Immune System Diseases (8) · Hypersensitivity (3) · Nut and Peanut Hypersensitivity (3) · Chemically-Induced Disorders (2) · Autoimmune Diseases (1) · Drug-Related Side Effects and Adverse Reactions (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
Control Groups (1) · Glycerol (1) · Patch Tests (1)
Mahidol University (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Allertein Therapeutics, LLC (1) · Assistance Publique - Hôpitaux de Paris (1) · Johns Hopkins University (1) · University Hospital, Antwerp (1)
United States (4) · Thailand (2) · Belgium (1) · France (1)
Robert Wood, MD (3) · David Fleischer, MD (2) · Nualanong Visitsunthorn, Prof (2) · Scott Sicherer, MD (2) · Stacie Jones, MD (2) · Wesley Burks, MD (2) · Agnes Sola-Gazagnes, MD (1) · Hugh A. Sampson, MD (1) · Robert A. Wood, MD (1) · Vera Saldien, MD,PhD (1)
PMID 1460201, PMID 22808958, PMID 23265698, PMID 25528358, PMID 25656999, PMID 26924470, PMID 35505238
U19AI066738 (1)